Certainly some division in analysts opinion on BCRX. I can't figure it out either, but while the street values this stock at little more than the cash they hold and limited revenue they generate, analysts are remaining optimistic. In just about any other biotech stock that crashed like this, I would expect most, if not all, analysts to distance themselves, but that hasn't been the case here.
I can't believe they were shorting this stock and then covered some @7. If they were shorting, they would have waited.. If they are long, they would surely average down with some buying here.
..also, If BB's bought @ around $7, they would surely buy more here if they believed the price will go up. I'm curious if they will buy more.
..not to mention the insider buying with options to buy where the price was higher than this..